A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients
暂无分享,去创建一个
Y. Sugiyama | H. Date | K. Sugio | J. Nakajima | M. Ebina | H. Kondo | A. Watanabe | H. Horio | S. Teramukai | K. Kishi | T. Kondo | N. Okumura | J. Okami | H. Niwa | Toshihiko Sato
[1] Kenji Suzuki,et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. , 2014, The Journal of thoracic and cardiovascular surgery.
[2] A. Wells,et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2013, Respiration.
[3] T. Higami,et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis , 2013, General Thoracic and Cardiovascular Surgery.
[4] Luca Richeldi,et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. , 2011, The New England journal of medicine.
[5] Yukiko Nakamura,et al. The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[6] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[7] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[8] G. Raghu,et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.
[9] D. Lynch,et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[10] I. Yoshino,et al. Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography , 2011, Surgery Today.
[11] E. Miyaoka,et al. Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002 , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[12] Jong-Min Song,et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.
[13] Y. Ohno,et al. Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer , 2010, General thoracic and cardiovascular surgery.
[14] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[15] M. Raza. BUILD-1: A Randomized Placebo-Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis , 2009 .
[16] A. Yoshimura,et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. , 2009, Internal medicine.
[17] M. Nishimura,et al. Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosis , 2006, Respirology.
[18] S. Kudoh,et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.
[19] T. D’amico,et al. Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection , 2004, Seminars in cardiothoracic and vascular anesthesia.
[20] N. Kohno. [Sialylated carbohydrate antigen KL-6]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.
[21] G. Raghu,et al. The epidemiology of interstitial lung disease and its association with lung cancer , 2004, British Journal of Cancer.
[22] A. Nicholson,et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. , 2003, The Journal of thoracic and cardiovascular surgery.
[23] D. Schroeder,et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. , 2001, The European respiratory journal.
[24] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[25] N. Kohno,et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. , 1989, Chest.
[26] A. Kondoo. Acute Exacerbation in Idiopathic Interstitial Pneumonia , 1989 .